Evidence map›Paper›PMID 24603758›Full record

ArticlePloS one2014

The whole set of constitutive promoters recognized by RNA polymerase RpoD holoenzyme of Escherichia coli.

Tomohiro Shimada, Yukiko Yamazaki, Kan Tanaka, Akira Ishihama

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tazobactam selects for multidrug resistance.npj antimicrobials and resistance · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Genomic SELEX Screening of Regulatory Targets of Transcription Factors.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  17. Deep Learning-Assisted Design of Novel Promoters inAdvanced genetics (Hoboken, N.J.) · 2023
    Article
  18. Sense and antisense RNA products of theFrontiers in molecular biosciences · 2023
    Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tomohiro ShimadaDepartment of Frontier Biosience, Hosei University, Koganai, Tokyo, Japan; Micro-Nano Technology Research Center, Hosei University, Koganai, Tokyo, Japan; Chemical Resources Laboratory, Tokyo Institute of Technology, Nagatsuda, Yokohama, Japan.
Yukiko YamazakiGenetics Strains Research Institute, National Institute of Genetics, Mishima, Shizuoka, Japan.
Kan TanakaChemical Resources Laboratory, Tokyo Institute of Technology, Nagatsuda, Yokohama, Japan.
Akira IshihamaDepartment of Frontier Biosience, Hosei University, Koganai, Tokyo, Japan; Micro-Nano Technology Research Center, Hosei University, Koganai, Tokyo, Japan.
Hosei University · JPNational Institute of Genetics · JPTokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The promoter selectivity of Escherichia coli RNA polymerase is determined by the sigma subunit with promoter recognition activity. The model prokaryote Escherichia coli contains seven species of the sigma subunit, each recognizing a specific set of promoters. The major sigma subunit, sigma-70 encoded by rpoD, plays a major role in transcription of growth-related genes. Concomitant with the increase in detection of promoters functioning in vivo under various stressful conditions, the variation is expanding in the consensus sequence of RpoD promoters. In order to identify the canonical sequence of "constitutive promoters" that are recognized by the RNA polymerase holoenzyme containing RpoD sigma in the absence of supporting transcription factors, an in vitro mixed transcription assay was carried out using a whole set of variant promoters, each harboring one base replacement, within the model promoter with the conserved -35 and -10 sequences of RpoD promoters. The consensus sequences, TTGACA(-35) and TATAAT(-10), were identified to be ideal for the maximum level of open complex formation and the highest rate of promoter opening, respectively. For identification of the full range of constitutive promoters on the E. coli genome, a total of 2,701 RpoD holoenzyme-binding sites were identified by Genomic SELEX screening, and using the reconfirmed consensus promoter sequence, a total of maximum 669 constitutive promoters were identified, implying that the majority of hitherto identified promoters represents the TF-dependent "inducible promoters". One unique feature of the constitutive promoters is the high level of promoter sequence conservation, about 85% carrying five-out-of-six agreements with -35 or -10 consensus sequence. The list of constitutive promoters provides the community resource toward estimation of the inducible promoters that operate under various stressful conditions in nature.

Indexed as

GenomicsBinding SitesConsensus SequenceDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsFimbriae ProteinsGene SilencingGenome, BacterialHoloenzymesPromoter Regions, GeneticProtein BindingSigma FactorSubstrate SpecificityDNA-Directed RNA PolymerasesEscherichia coli ProteinsFimbriae ProteinsFimG protein, E coliHoloenzymesRNA polymerase sigma 70Sigma Factor

Identifiers

PMID24603758
PMCPMC3946193
OpenAlexW2005166450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.